NCT01755702 Paracetamol With Caffeine to Treat Episodic Tension Type Headache Status TERMINATED Phase PHASE2/PHASE3
NCT01755689 Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Meningococcal Vaccine With or Without Co-administration of Cervarix and Boostrix in Female Adolescents and Young Adults Status COMPLETED Phase PHASE3
NCT01755637 Bioequivalence Study of Albendazole 400 mg Tablets in Chinese Population Status COMPLETED Phase PHASE1
NCT01755598 Study to Evaluate the Efficacy of GlaxoSmithKline (GSK) Biologicals' Candidate Tuberculosis (TB) Vaccine in Adults Status COMPLETED Phase PHASE2
NCT01754116 A Randomized Study to Assess the Relative Bioavailability of New Formulations of GSK1265744 Long Acting Parental (LAP) in Healthy Adult Subjects Status COMPLETED Phase PHASE1
NCT01753076 Study of Ozanezumab (GSK1223249) Versus Placebo in the Treatment of Amyotrophic Lateral Sclerosis Status COMPLETED Phase PHASE2
NCT01751165 Safety and Immunogenicity of Different Dosing Schedules of GlaxoSmithkline (GSK) Biologicals' Herpes Zoster (HZ) Vaccine in Adults 50 Years of Age or Older Status COMPLETED Phase PHASE3
NCT01751139 An Epidemiological Surveillance Study to Evaluate the Incidence of Dengue in Brazil Status TERMINATED Phase NA
NCT01751113 A 3 Way Cross-over Study Evaluating the Effects of ADOAIR Twice Daily Plus Tiotropium Bromide Once Daily Compared With the Individual Treatments of Japanese Subjects Status COMPLETED Phase PHASE4
NCT01751074 To Estimate the Potential Effects of Repeat Doses of Darapladib on the Pharmacokinetics (PK) of Rosuvastatin as Well as Evaluating Safety and Tolerability in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT01750931 This Study is Randomised, Single Oral Dose Bioequivalence Study of Meloxicam GSK 15 MG Tablets. Status COMPLETED Phase NA
NCT01750827 A Study to Assess the Effect of SB 659032 on Platelet Function Status COMPLETED Phase PHASE1
NCT01746108 Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Pneumococcal Vaccine (Synflorix™) When Administered to Children Who Are at an Increased Risk of Pneumococcal Infection Status COMPLETED Phase PHASE3